ArticleScientific reports2025
Polymorphisms in SAA alter intrarenal amyloid distribution of AA amyloidosis in cats.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Systemic amyloid A amyloidosis secondary to presumed chronic vertebral osteomyelitis and pressure ulcers in a mandrill (Mandrillus sphinx).The Journal of veterinary medical science · 2026Article
- Systemic apolipoprotein C-III amyloidosis in an Asian lion (Panthera leo persica).The Journal of veterinary medical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The kidneys are one of the primary organs affected by amyloid A (AA) amyloidosis in mixed-breed cats. The distribution of amyloid deposits within the kidneys varies among individuals; however, the underlying cause is unknown. This study investigated the association between serum AA (SAA) polymorphisms and the pattern of renal amyloid deposition in five mixed-breed cats. Histological analysis of the kidneys revealed amyloid deposits in the renal glomeruli and renal papillae in all cases. In contrast, the amyloid deposition pattern differed in the medulla, with widespread deposition from the corticomedullary junctional area to the inner medulla in two of the five cats. These amyloids were mainly located in the basement membrane of the renal tubules, extending towards the lumen and into the interstitium. Conversely, in the other three cats, amyloid deposition in the medulla was sparse and the deposits were localized in the perivascular stroma in the corticomedullary junction. Genetic analysis identified four SAA alleles involving six amino acid substitutions (Q1E, I29K, D42E, Q45R, P48R, and A51V). Mass spectrometry and immunohistochemistry revealed that AA amyloid derived from SAA with Q45 was predominantly deposited in the cortex and papilla, as well as in the perivascular stroma of some parts of the outer medulla. On the other hand, AA amyloid derived from SAA with R45 was specifically observed around the tubules in the renal inner to outer medulla. Except for Q45R, no substitutions were associated with distribution patterns. These findings suggest that the SAA polymorphism sequence is associated with the site of AA amyloid deposition in the kidney. Moreover, this study is the first report of such a complex pattern of amyloid deposition in the organ of the same individual, emphasizing that the primary structure of the amyloid precursor protein determines amyloid distribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.